Radiopharm Theranostics Ltd (RADX)
Data as of , from SEC Form 4 filings.
See up to 3 months of RADX. The 7-day demo opens the 1M and 3M ranges and puts RADX on your watchlist.
Start 7-day demoLatest RADX insider trades
About Radiopharm Theranostics Ltd (RADX)
Radiopharm Theranostics Ltd is a clinical-stage radiotherapeutics company focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. It develops and commercializes radiopharmaceutical platforms for therapeutic and diagnostic applications in precision oncology. The Company develops targeted and scientifically validated radiopharmaceutical technologies in pre-clinical and clinical stages. It has one reportable segment, being the research, development, and commercialization of health technologies. The Company operates in Australia and the United States, with maximum revenue from the United States.
- 14
- 2024
- Nasdaq
https://www.radiopharmtheranostics.comSEC filings for RADX on EDGAR
RADX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 30,887,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
RADX insider transactions (Form 4)
31 Form 4 filing on record, the earliest from Oct 27, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dimitris Voliotis - Officer | Grant or award | Option (Right to buy) | 10,295,667 | $0.00 | - | |
| Dimitris Voliotis - Officer | Grant or award | Option (Right to buy) | 10,295,667 | $0.00 | - | |
| Dimitris Voliotis - Officer | Grant or award | Option (Right to buy) | 10,295,666 | $0.00 | - |
RADX insider trading FAQ
What is the latest insider trade for RADX?
Radiopharm Theranostics Ltd (RADX) had 1 insider filing in the last 90 days, with the most recent on 27 October 2026. The full record for RADX runs to 1 Form 4 filing, the earliest from 27 October 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RADX stock?
No insider purchases of RADX were filed in the last 90 days.
How many insiders are selling RADX stock?
No insider sales of RADX were filed in the last 90 days.
Where can I see RADX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RADX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
1The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Dimitris Voliotis view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where RADX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RADX with a 7-day demo
- RADX on your watchlist
- Every RADX Form 4 filing on record
- Up to 3 months of RADX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
